Arima Genomics announced that it will present new data at the Association for Molecular Pathology (AMP) 2025 Annual Meeting.

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

Monopar Therapeutics Inc. (NASDAQ:MNPR) stock gained 4.1% in premarket trading Monday following the company’s presentation of ...

Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

Investigator-initiated study shows potential for EchoSolv AS to drive improved patient outcomes when used to support cardiologist in identifying severe AS particularly in womenNEDA study of 1.2M ...

Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis ...

First presentation of U.S. IDE clinical data shows statistically significant improvements in pain and function at 24 months ...

If claiming for a Documented Loss Cash Payment for the AT&T 1 Data Incident and a Documented Loss Cash Payment for the AT&T 2 ...